Everything you need to diagnose and treat BHRT and Thyroid disorders for men and women. The course includes didactic training for pellet and non-pellet hormones, as well as legal considerations, and consent forms, and everything you need to start practicing.
Videos, reference materials, consents, forms, guidebooks
Lifetime access to the materials
Industry expert trainers Dr. Angela DeRosa & Dr. Melissa Loseke
Exclusive: Live peer to peer community and knowledge base to review and ask questions from others in the course
TO VIEW THE CURRICULUM EXPAND THE ARROWS NEXT TO THE TOPICS BELOW
Welcome to the CME Masterclass: BHRT & Thyroid & Summary Dosing Reference Guide
Accreditation Statement & Disclosures
Summary of BHRT Dosing
How to properly assess BHRT patient cases
Hormone Therapy 101 ( 31- minute lecture)
Hormones 101 Lecture Notes
Hormone Therapy 101 For Males ( 40-minute lecture)
Hormone Therapy 101: Male Patients Lecture Notes
Hormone Cascade Diagram
Reference: Menopause-Rating-Scale-MRS
AMS_English
ADAM Questionnaire
Assessing Hormonal Labs ( 74-minute lecture)
Proper Interpretation of BHRT Labs: Male & Female Patients Lecture Notes
Reference: Optimal LAB Panels v3
Female Lab Exam
Staging Female Patients ( 46-minute lecture)
Hormone Decline & Staging in Female Patients Lecture Notes
Reference: Stages of Hormone Decline in Women with Pellet Dosing
Birth Control Options: The Good. The Bad. The Ugly. ( 32-minute video)
Birth Control Options: The Good. The Bad, The Ugly Lecture Notes
Reference: Oral Birth Control Pills
Pros & Cons of Different HRT Options ( 38-minute lecture)
Pros and Cons of Different BHRT Treatment Options Lecture Notes
Reference: HRT Options Pros and Cons
Dosing Non-Pellet Options ( 74-minute lecture)
Dosing Non-Pellet BHRT Treatment Options Lecture Notes
Reference: Non-Pellet Dosing Options (Females)
Post Menopausal Progesterone and Break Through Bleeding Protocols (23-minute lecture)
Progesterone & Uterine Bleeding Protocols Lecture Notes
Reference: Progesterone and Bleeding Protocol
Management of Side Effects and Adverse Events ( 36-minute lecture)
How to Manage Adverse Effects of BHRT Lecture Notes
Management of Side Effects & Adverse Effects of HRT
Pellet Dosing Protocols ( 54-minute lecture)
How to Properly Dose Pellets & Pellet Case Studies Lecture Notes
Reference: Female Pellet Dosing
Reference: Male Pellet Dosing
Pellet Insertion Training for Female Patients ( 12-Minute Video Demonstration)
Pellet Insertion Video Male Patient ( 17-Minutes)
Pellet Insertion Training Manual
Thyroid Evaluation & Lab Interpretation ( 49-minute lecture)
Thyroid Evaluation and Lab Interpretation Notes
Thyroid Case Studies ( 36-minute lecture)
Thyroid Management & Treatment with Case Studies Notes
Reference: Hypothyroidism
How to Protect from Legal & Board Action ( 31-minute video)
How to Protect Yourself from Legal & Board Action
Forms & Consents
ABN's
Female EMR Templates & Consent Forms
Flowsheets
Inventory Management
Male EMR Templates & Consent Forms
New Patient Paperwork
Post Pellet Insertion Patient Instructions
Questionnaires
Federation Guidelines
Bio-identical Hormone Therapy & Thyroid Evaluation & Treatment Examination
How to Claim CME Credit: Instructions
Destroying the Myth about Testosterone Replacement Prostate Cancer
Hormone Cascade (1)
Risk of Testosterone-Replacement Therapy
Death by T
DeRosaRebuttal to Pellet study June 2020
Federation-guidelines (1)
Glaser Dim 13 Reduced BCA incidence T T+ A (1)
How to properly assess BHRT patient cases
NAMS-2017-hormone-therapy-position-statement (1)
Myths about T1
Postmenopausal hormone therapy for cardiovascular health - the evolving data
Global Consensus Statement on Menopausal Hormone Therapy
Gender Bias in Medicine
Donovitz_Low_Complication_Rates_of_Testosterone_and_Estradiol_Implants_for_Androgen_and_Estrogen_Replacement_Therapy_in_Over_One_Million_Procedures
Peripheral thryoid conversion
FSH blocking agent development 2020 (1)
Impact of Micronized Progesterone on Breast Cancer
Testosterone and prostate
Subcutaneous Testosterone Anastrazole Therapy in Men
SUMMARY OF BHRT DOSING
Testosterone Supplementation in Women
Testosterone in Women International Consensus
HRT geriatric thyroid A4m (1) (1)
Tesosterone implants in women Glaser
Testosterone Therapy and Cardiovascular Risk
Updated_Donovitz_European_Journal_of_Breast_Health_April_2021
Testosterone and the Female Voice
TSH_Proves_to_be_an_unreliable_test_for_Hypothyroidism
Thyroid-Hormone-Transport-into-Cellular-Tissue
Testosterone Implant Therapy in Women With and Without Breast Cancer
The Aging Male, 2018
What are we to believe
Thyroid and cellular transport
Hypothyroidism_low thyroid function_ Vasquez
Testosterone Implants in Women
How accurate is TSH testing (1)
Safety_and_efficacy_cBHT meta analysis: 2022 April The Journal of The North American Menopause Society
Breast cancer time for a change 2021: American Society of Clinical Oncology
Include:
1. Summarize the indications and contraindications for the use of estradiol, progesterone, testosterone thyroid replacement
2. Discuss clinical information for the use of estradiol, progesterone, testosterone and thyroid in patients diagnosed with hormonal deficiencies and explain how to clinical apply this knowledge in clinical practice
3. Recall menopausal and andropausal basics and how to properly identify and assess hormone deficiency in men and women
4. Review the evidence related to breast cancer, prostate cancer, cardiovascular disease as well as other clinical outcomes related to hormone replacement in men and women
5. Describe how to manage the most common adverse events from hormonal therapies as well as the specifics related to pellet therapies
6. Review the different mechanisms of action of each birth control option and how they impact hormonal balance in women
7. Identify how to properly interpret hormonal labs in men and women as well as understand how to target “optimal” results post treatment
8. Recall how to properly dose pellet and non-pellet therapies in men and women
9. Describe how to properly dose thyroid replacements and which medications are best suited for each individual patient based on proper evaluation of their thyroid lab panels
10. Identify the proper pellet insertion techniques for both men and women
Angela DeRosa, DO, MBA, CPE
Dr. DeRosa’s appointment also gives Belmar the opportunity to align with the Hormonal Health Institute (HHI), a hormonal health consultancy founded by Dr. DeRosa in 2018. HHI offers physicians and clinical professionals medical and practice development training on bio-identical hormonal replacement therapy (BHRT), with an emphasis on pellet therapy. Through HHI, Belmar will offer its providers free monthly webinars and discounts on best-in-class training.
“Over the course of her career, Dr. DeRosa’s mission has been to change the face of women’s health and wellness by emphasizing the importance of balanced hormones as a foundation for optimal health. Belmar specializes in bio-identical hormone replacement therapy and other hormone-based wellness products, so naturally we’re excited to have Dr. DeRosa join our team,” Belmar CEO Dave Hill said. “Belmar and our providers will benefit immensely from both Dr. DeRosa’s vast expertise and experience as well as the resources of the Hormonal Health Institute.”
Dr. DeRosa has more than 25 years of experience in the medical field, both on the pharmaceutical side and in clinical practice. She served for several years as Senior Medical Director at Proctor & Gamble Pharmaceuticals, with a focus on the women’s health lines of osteoporosis and female sexual health. A board-certified internist with a specialty background in women’s health, Dr. DeRosa is the Founder and President of DeRosa Medical and DRM Integrative Health, where she treated over twenty thousand patients using advanced BHRT and optimization.
Dr. DeRosa is also an accomplished author, lecturer, and published researcher. After the publication of her first book, How Your Doctor Is Slowly Killing You: A Woman’s Health Survival Guide, in 2016, Dr. DeRosa received an avalanche of requests from physicians across the country wanting to learn more. The response was so overwhelming that Dr. DeRosa decided to launch the Hormonal Health Institute to share her knowledge with physicians and other medical healthcare providers in order to help change the face of women’s healthcare.
Dr. DeRosa received a Doctorate of Osteopathic Medicine from Midwestern University as well as a Master’s in Medical Management from Amherst College. She serves as Clinical Assistant Professor at Midwestern University, Arizona College of Osteopathic Medicine, and Clinical Assistant Professor of the Department of Internal Medicine at the University of Arizona College of Medicine-Phoenix. In addition to being Immediate Past President of the Arizona Osteopathic Medical Association, she is also a member of the International Menopause Society, the European Endocrine and Menopause Society, and the International Society of the Study of Women’s Sexual Health.
“As someone who’s long been impressed with Belmar’s dedication to patients’ health and its commitment to quality without compromise, I’m very excited to serve as its Medical Director,” Dr. DeRosa said. “While I’ve had a very diverse career path, one constant has been my commitment to the understanding of hormones and the role they play not only in the quality of life, but at preventing chronic illness. As Belmar Medical Director, I’m looking forward to sharing my knowledge and experience with Belmar’s providers.”
Melissa Loseke Ablett, DO
